Toxicity Due to Radiotherapy
13
3
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma
Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer
Impact of Gonadotoxic Therapies on Fertility
IMRT Versus 3DCRT for Locally Advanced Rectal Cancer, Prospective Phase II Study.
Thermal Testing in Bone Pain (TiBoP)
Supplementation With Dietary Anthocyanins and Side Effects of Radiotherapy for Breast Cancer
Prostate Cancer Stereotactic Radiotherapy
The Association of hsCRP and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma
Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.
REBECCA Study (RadiothErapy for BrEast Cancer and CArdiotoxicity)
Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer
GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China